John A III Stalfort
CIK 1709418 · last filed 2026-06-05
John A III Stalfort is a corporate insider who has filed 19 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing, for ABOS, was dated Jun 5, 2026. Across all open-market trades the lifetime net is +$2.3M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $23.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$23.34M
4
19
$2.25M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ABOS | Director | 352,219 | $2.37 | $834.8K | $560.0K | 7 | 2026-06-05 |
| TSHA | Director | 2,060,849 | $5.71 | $11.77M | $700.0K | 5 | 2026-06-02 |
| VRCA | Director | 1,873,800 | $5.73 | $10.74M | $796.8K | 5 | 2024-11-26 |
| Dova Pharmaceuticals Inc. (DOVA) Delisted | Director | 0 | — | — | $194.1K | 2 | 2019-11-12 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | ABOS | Grant (A) | +35,500 | $0 | EDGAR |
| 2026-06-02 | TSHA | Grant (A) | +21,335 | $0 | EDGAR |
| 2025-06-05 | ABOS | Grant (A) | +12,800 | $0 | EDGAR |
| 2025-06-04 | TSHA | Grant (A) | +56,623 | $0 | EDGAR |
| 2024-11-26 | VRCA | Mixed | +1,173,595 | $0 | EDGAR |
| 2024-06-10 | ABOS | Grant (A) | — | $0 | EDGAR |
| 2024-05-31 | TSHA | Grant (A) | +49,220 | $0 | EDGAR |
| 2023-08-16 | TSHA | Mixed | +827,778 | $700.0K | EDGAR |
| 2023-06-26 | TSHA | Grant (A) | — | $0 | EDGAR |
| 2023-06-07 | ABOS | Grant (A) | — | $0 | EDGAR |